My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 103

    1.

    Simulated physician learning intervention to improve safety and quality of diabetes care: a randomized trial.

    O'Connor PJ, Sperl-Hillen JM, Johnson PE, Rush WA, Asche SE, Dutta P, Biltz GR.

    Diabetes Care. 2009 Apr;32(4):585-90. Epub 2009 Jan 26.PMID: 19171723 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Customized feedback to patients and providers failed to improve safety or quality of diabetes care: a randomized trial.

    O'Connor PJ, Sperl-Hillen J, Johnson PE, Rush WA, Crain AL.

    Diabetes Care. 2009 Jul;32(7):1158-63. Epub 2009 Apr 14.PMID: 19366977 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

    Roberts VL, Stewart J, Issa M, Lake B, Melis R.

    Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

    4.

    WellDoc mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction.

    Quinn CC, Clough SS, Minor JM, Lender D, Okafor MC, Gruber-Baldini A.

    Diabetes Technol Ther. 2008 Jun;10(3):160-8.PMID: 18473689 [PubMed - indexed for MEDLINE]Related articles

    5.

    United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.

    [No authors listed]

    Ann Intern Med. 1998 Feb 1;128(3):165-75.PMID: 9454524 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Favorable effects of pioglitazone and metformin compared with gliclazide on lipoprotein subfractions in overweight patients with early type 2 diabetes.

    Lawrence JM, Reid J, Taylor GJ, Stirling C, Reckless JP.

    Diabetes Care. 2004 Jan;27(1):41-6.PMID: 14693964 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

    Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group.

    Ann Intern Med. 2005 Oct 18;143(8):559-69.PMID: 16230722 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial.

    Aubert RE, Herman WH, Waters J, Moore W, Sutton D, Peterson BL, Bailey CM, Koplan JP.

    Ann Intern Med. 1998 Oct 15;129(8):605-12.PMID: 9786807 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

    Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

    Clin Ther. 2004 May;26(5):744-54.PMID: 15220018 [PubMed - indexed for MEDLINE]Related articles

    10.

    Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

    Rosenstock J, Sugimoto D, Strange P, Stewart JA, Soltes-Rak E, Dailey G.

    Diabetes Care. 2006 Mar;29(3):554-9.PMID: 16505505 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

    Lewin A, Lipetz R, Wu J, Schwartz S.

    Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

    12.

    Teleconferenced educational detailing: diabetes education for primary care physicians.

    Harris SB, Leiter LA, Webster-Bogaert S, Van DM, O'Neill C.

    J Contin Educ Health Prof. 2005 Spring;25(2):87-97.PMID: 16078807 [PubMed - indexed for MEDLINE]Related articles

    13.

    Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

    Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

    Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947. PMID: 11874944 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.

    Suppapitiporn S, Chindavijak B, Onsanit S.

    J Med Assoc Thai. 2005 Sep;88 Suppl 4:S134-41.PMID: 16623018 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis.

    Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, Owens DK.

    JAMA. 2006 Jul 26;296(4):427-40. Review.PMID: 16868301 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.

    Dailey GE 3rd, Mohideen P, Fiedorek FT.

    Clin Ther. 2002 Sep;24(9):1426-38.PMID: 12380634 [PubMed - indexed for MEDLINE]Related articles

    17.

    A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors.

    Kirkman MS, Weinberger M, Landsman PB, Samsa GP, Shortliffe EA, Simel DL, Feussner JR.

    Diabetes Care. 1994 Aug;17(8):840-6.PMID: 7956628 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    19.

    One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.

    Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH; QUARTET Study Group.

    Diabetes Care. 2004 Jan;27(1):141-7.PMID: 14693980 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial.

    Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H; COMPETE II Investigators.

    CMAJ. 2009 Jul 7;181(1-2):37-44.PMID: 19581618 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity